This project

is developed

by TIRFbio

T: 919.463.9545

i-Diagnostics® 5D
The Handheld Future of Precision Medicine

Copyright © 2021, TIRFbio, Inc. All photographic images, schemes and text located at this web site are protected by US copyright laws and international treaties.

To use them, please contact TIRFbio at: Include a description of the purpose and location for placement.  

Terms and ConditionsPrivacy PolicyLiterature Cited FDA ComplianceBlog Copyright Credits

In eget sapien vitae massa rhoncus lacinia. Nullam at leo nec metus aliquam semper.

Curabitur felis erat, tempus eu, placerat et, pellentesque sed, purus. Sed sed diam.

Nulla quis nibh. Proin ac pede vel


Quisque pellentesque metus ac quam. Donec magna nulla, aliquet vitae, congue

Nulla vestibulum eleifend nulla.


Quisque pellentesque metus ac quam. Donec magna nulla, aliquet vitae, congue

Vestibulum velit orci, bibendum


In hac habitasse platea


Mauris purus. Donec est nunc, ornare non, aliquet non, tempus vel, dolor. Integer sapien nibh, egestas ut, cursus sit amet, faucibus a, sapien. Vestibulum purus purus, elementum ac, luctus ullamcorper, ornare vitae, massa. Nullam posuere sem ut mauris. Nullam velit. Quisque sodales.

In hac habitasse platea

Morbi pellentesque, mauris interdum porta

Aliquam pulvinar congue pede. Fusce condimentum turpis vel dolor. Ut blandit. Sed elementum justo quis sem. Sed eu orci eu ante iaculis accumsan. Sed suscipit dolor quis mi. Curabitur ultrices nonummy lacus. Morbi ipsum ipsum, adipiscing eget, tincidunt vitae, pharetra at, tellus. Nulla gravida, arcu eget dictum eleifend, velit ligula suscipit nibh, sagittis imperdiet metus nunc non pede. Aenean congue pede in nisi tristique interdum. Sed commodo, ipsum ac dignissim ullamcorper, odio nulla venenatis nisi, in porta dolor neque venenatis lacus. Pellentesque fermentum. Mauris sit amet ligula ut tellus gravida mattis. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia



Maecenas condimentum tincidunt lorem. Vestibulum vel tellus. Sed vulputate. Morbi massa

Vestibulum semper enim non eros. Sed vitae arcu. Aliquam erat volutpat. Praesent

Quisque pellentesque metus ac


Vivamus vel sapien. Praesent nisl tortor, laoreet eu, dapibus quis, egestas non, mauris. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Nullam eleifend pharetra felis. Mauris nibh velit, tristique ac, lacinia in, scelerisque et, ante. Donec viverra tortor sed nulla. Phasellus nec magna. Aenean vehicula, turpis in congue eleifend, mauris lorem aliquam sem, eu eleifend est odio et

Vivamus vel sapien.

Morbi pellentesque, mauris interdum porta tincidunt, neque orci molestie mauris, vitae iaculis dolor felis at nunc. Maecenas eu diam a leo porta interdum. In non massa quis odio feugiat sagittis. Quisque ac lorem. Maecenas ut sem sed ipsum suscipit malesuada. Nulla quis dui quis ante fermentum interdum. Proin eget est a augue vehicula mattis. Pellentesque sed nisi at nisi

Suspendisse sem lorem, ornare

Open Source Platform Technology

Open Innovation Business Model

i-Diagnostics is a very large scale project. It involves multiple dimensions in many areas, including creating biological defense infrastructure and a social network. It will establish a new type of collaboration between research groups involved in different aspects of diagnostics. It is infeasible for a single group or organization to address the numerous challenges each application presents. To address this limitation, i-Diagnostics has chosen a unique approach that is fueled by the collective global effort of scientists, engineers, businessmen, and administrators in the framework of Open Innovation Business Model. More about the principles of Open Innovation Business Model (OIBM) here.

In the field of information technologies, Linux is an example of a project that followed an OIBM. As a result, Linux became ubiquitous and invited many collaborators from around the world. Arduino is an example of OIBM application for the open-source electronic prototyping platform enabling users to create interactive electronic objects. Arduino also became omnipresent platform, for which customers/collaborators created countless applications. We envision a model similar to Arduino and Linux, but in the area of molecular diagnostics. Open Innovation will stimulate the exchange of Intellectual Property (IP) between collaborators.  i-Diagnostics will become an open-source biodetection platform for thousands of molecular diagnostics applications. To facilitate these tasks TIRFbio will supply TIRF hardware, software, cartridge blanks, development tools, reagent kits, methods and protocols to our collaborators and development customers to help interface their existing bioassays with the i-Diagnostics platform and develop new assays. TIRFbio plans to offer IP licensing to our collaborators and will offer them the opportunity to license our IP (in certain instances free of charge) to develop precise, rapid, and still affordable devices for molecular diagnosis and prognosis. To enable all of the stages of this challenging project, from biomarker discovery, to clinical testing, TIRFbio offers the uTIRF Biodetection Station and the Application Development Kit (ADK). ADK-uTIRF products are available to all members of the diagnostic community, including academic, industrial, and government research groups and are essential to the Open Innovation Business Model.

Due to the Open Innovation Business Model, our collaborators and customers will be able not only innovate outside the i-Diagnostics biodetection boundaries, but will be welcome to innovate within i-Diagnostics platform. The architecture of i-Diagnostics cradle, cartridges and sample preparation elements is largely modularized according to their functions, which allows for changing each function independently of the rest of the system. TIRFbio pursues the objective to modularize the i-Diagnostics platform so that one core function is contained in one hardware module. We apply similar philosophy to i-Diagnostics software as well. Our approach involves standardization of modules and interfaces. Certain design rules need to be followed to seamlessly interface the innovative module into the platform. This allows for combining theoretically unlimited number of modules, similar to LEGO pieces.

In TIRFbio  we have started to practice the Open Innovation Business Model, when we supplied first units of the uTIRF biodetection station and Application Development Kit (ADK) to our collaborators and customers. The feedback that we have received from them has inspired us to to further improve the versatile uTIRF biodetection station, expand the ADK and plan the creation of a dedicated department to efficiently support the developments and innovations of our customers and collaborators. TIRFbio seeks funds to establish such department. Our first customers and collaborators rapidly generated dozens of other applications related to molecular diagnostics, including biomarker discovery, elucidating the mechanisms of disease, routine clinical analyses, and even the measurement of chemical analytes. Applications for the i-Diagnostics platform include the diagnosis and prognosis of cancer, heart diseases, infectious diseases, including STD, longevity studies, food and water safety, military, forensic, environmental, and agricultural applications, as well as disease prevention actions and counter-measures against bioterrorism and naturally occurring diseases. For more information about i-Diagnostics applications click here.

Open Innovation Business Model